Cellvie is a seed startup based in Switzerland. 1 investor tracked on Brouky Intelligence. Data sourced from Brouky Intelligence.
About
A biotechnology company pioneering Therapeutic Mitochondria Transplantation (TMT) as a new treatment modality for ischemia-reperfusion injuries (IRI), which occur when blood flow is restored to tissues after a period of oxygen deprivation.
Stage
seed
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky